Besides its virtual monomorphism, another advantage of targeting HLA-E by vaccination is that HLA-E is not downregulated upon HIV co-infection, in contrast to classical HLA-I molecules, which is an important benefit as infection with HIV and TB significantly overlap in endemic areas [23]. The gene discussed is HLA-E; the disease is infection.